Literature DB >> 12695843

Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non- Pneumocystis carinii pneumonia in AIDS patients.

A Hidalgo1, V Falcó, S Mauleón, J Andreu, M Crespo, E Ribera, A Pahissa, J Cáceres.   

Abstract

The aim of this study was to assess the value of high-resolution CT in distinguishing between Pneumocystis carinii and non- Pneumocystis carinii pneumonia (PCP) in patients HIV-positive and high risk to have PCP. We performed a prospective study in 30 patients with <200 CD4 lymphocytes, clinical symptoms of pulmonary disease and chest X-ray non-conclusive for pulmonary infection. Evaluated CT findings included ground-glass opacities, reticulation, tree-in-bud appearance, consolidation, cystic lesions, bronchiectasis and lymphadenopathies. The diagnosis of "examination suggestive of PCP" was applied to cases showing a diffuse or predominant ground-glass pattern in the upper fields, associated or not with reticulations and small cystic lesions. The sensitivity, specificity, positive predictive value and negative predictive value of high-resolution computed tomography (HRCT) for the diagnosis of PCP was 100, 83.3, 90.5 and 100%, respectively. Pneumocystis carinii pneumonia was not demonstrated in any of the cases classified as "examination not suggestive of PCP". Significant small airway disease was not observed in any of the PCP cases. We conclude that HRCT is a reliable method for differentiating PCP from other infectious processes in HIV-positive patients and a good method to rule our PCP. Its inclusion in the diagnostic algorithm of lung infections is justified in these patients.

Entities:  

Mesh:

Year:  2002        PMID: 12695843     DOI: 10.1007/s00330-002-1641-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

Review 1.  Pneumonia in neutropenic patients.

Authors:  C P Heussel; H-U Kauczor; A J Ullmann
Journal:  Eur Radiol       Date:  2003-07-24       Impact factor: 5.315

Review 2.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort.

Authors:  Joseph K Leader; Kristina Crothers; Laurence Huang; Mark A King; Alison Morris; Bruce W Thompson; Sonia C Flores; Michael B Drummond; William N Rom; Philip T Diaz
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

5.  High-resolution computed tomography findings in an HIV-positive patient with swine-origin influenza A (H1N1) virus-associated pneumonia.

Authors:  Edson Marchiori; Gláucia Zanetti; Bruno Hochhegger; Klaus L Irion
Journal:  Br J Radiol       Date:  2010-02       Impact factor: 3.039

6.  Radiological features of Pneumocystis jirovecii Pneumonia in immunocompromised patients with and without AIDS.

Authors:  Emilia Hardak; Olga Brook; Mordechai Yigla
Journal:  Lung       Date:  2010-01-05       Impact factor: 2.584

7.  A practical approach to cystic lung disease on HRCT.

Authors:  Peter Beddy; Judith Babar; Anand Devaraj
Journal:  Insights Imaging       Date:  2010-11-12

8.  Acute microbiologically negative hypoxic interstitial pneumonia on HAART: Immune Reconstitution Inflammatory Syndrome unmasking Pneumocystis jiroveci infection with an atypical presentation.

Authors:  S Sovaila; A de Raigniac; C Picard; O Taulera; C Lascoux-Combe; D Sereni; A Bourgarit
Journal:  J Med Life       Date:  2012-06-18

Review 9.  Clinical review: Respiratory failure in HIV-infected patients--a changing picture.

Authors:  Putul Sarkar; Husham F Rasheed
Journal:  Crit Care       Date:  2013-06-14       Impact factor: 9.097

10.  Pneumocystis pneumonia in everolimus therapy: An indistinguishable case from drug induced interstitial lung disease.

Authors:  Toshio Suzuki; Yuji Tada; Kenji Tsushima; Jiro Terada; Takayuki Sakurai; Akira Watanabe; Yasunori Kasahara; Nobuhiro Tanabe; Koichiro Tatsumi
Journal:  Respir Med Case Rep       Date:  2013-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.